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The opportunistic pathogen Pseudomonas aeruginosa forms biofilms, which render it more resistant to
antimicrobial agents. Levels of iron in excess of what is required for planktonic growth have been shown to
promote biofilm formation, and therapies that interfere with ferric iron [Fe(III)] uptake combined with
antibiotics may help treat P. aeruginosa infections. However, use of these therapies presumes that iron is in the
Fe(III) state in the context of infection. Here we report the ability of phenazine-1-carboxylic acid (PCA), a
common phenazine made by all phenazine-producing pseudomonads, to help P. aeruginosa alleviate Fe(III)
limitation by reducing Fe(III) to ferrous iron [Fe(II)]. In the presence of PCA, a P. aeruginosa mutant lacking
the ability to produce the siderophores pyoverdine and pyochelin can still develop into a biofilm. As has been
previously reported (P. K. Singh, M. R. Parsek, E. P. Greenberg, and M. J. Welsh, Nature 417:552–555, 2002),
biofilm formation by the wild type is blocked by subinhibitory concentrations of the Fe(III)-binding innate-
immunity protein conalbumin, but here we show that this blockage can be rescued by PCA. FeoB, an Fe(II)
uptake protein, is required for PCA to enable this rescue. Unlike PCA, the phenazine pyocyanin (PYO) can
facilitate biofilm formation via an iron-independent pathway. While siderophore-mediated Fe(III) uptake is
undoubtedly important at early stages of infection, these results suggest that at later stages of infection, PCA
present in infected tissues may shift the redox equilibrium between Fe(III) and Fe(II), thereby making iron
more bioavailable.
Iron is an essential component of many metabolically im-
portant proteins in living cells. Because we live in an aerobic
world, it is often assumed that biologically available iron is
present in its ferric [Fe(III)] form and thus extremely limiting;
this is thought to be the case in diverse environments, ranging
from seawater to soils to the human body (47, 58). This limi-
tation arises from the fact that under aerobic, circumneutral
pH conditions, Fe(III) is present as highly insoluble Fe(III)
minerals or is tightly bound to mammalian host Fe(III)-seques-
tering proteins (1, 58). In the context of bacterial infections,
much attention has been placed on controlling bacterial
growth by limiting Fe(III) acquisition (4, 30, 68). This is espe-
cially relevant for Pseudomonas aeruginosa, an opportunistic
pathogen that infects the lungs of people with cystic fibrosis
(CF) (25). Not only is iron essential for its growth, but iron at
levels in excess of what is required for growth promotes biofilm
formation by signaling a transition from a motile to a sessile
state (5, 7, 51, 62, 68). As a biofilm, P. aeruginosa becomes
significantly more resistant to antimicrobial agents and much
more difficult to eradicate (13), which leads to an onslaught of
problems that compromise proper lung functioning, commonly
resulting in the morbidity and mortality of CF patients (13, 45).
Traditionally, studies of iron acquisition by P. aeruginosa
have focused on the Fe(III) uptake pathway mediated by het-
erogeneous siderophores, i.e., small molecules with high affin-
ity for binding Fe(III) (53, 64). Although in laboratory exper-
iments lactoferrin, an innate-immunity protein, was shown to
inhibit P. aeruginosa biofilm development by sequestering
Fe(III) from siderophores (5, 68), it is unclear whether this
occurs in vivo, because such inhibition may be compromised
due to cleavage of lactoferrin by cathepsins (62). Intriguingly,
P. aeruginosa strains present in advanced CF infections can
lose the ability to make the siderophore pyoverdine (16, 69),
and the iron content of CF sputum is often highly elevated
compared to that in the sputum of healthy controls (60). None-
theless, the actual chemistry of iron in CF sputum is poorly
defined and likely varies temporally for any given patient, from
patient-to-patient, and within any given microenvironment.
This is due to a complex set of interactions between the host
and microbial cells, some of which are just beginning to be
elucidated (23), that can affect the chemistry of iron and its
release (59). That said, it is reasonable to assume that if lac-
toferrin is present in sufficient amounts to bind Fe(III) on
mucosal surfaces, it would block biofilm formation at early
stages of infection (5, 68). Building on this finding, a novel
coculture system to permit the study of biofilm formation on
CF lung epithelial cells showed that cells harboring the F508
mutation (the most common mutation of the cystic fibrosis
transmembrane conductance regulator, CFTR) release signif-
icantly more iron than wild-type CFTR cells, stimulating bio-
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film formation by P. aeruginosa. In this system, chelation of
Fe(III) by conalbumin (a lactoferrin surrogate protein) dra-
matically reduced biofilm formation (45). A recent follow-up
study using this cell culture system showed that the combined
use of tobramycin and FDA-approved iron chelators reduced
biofilm biomass by approximately 90% (46).
While there is good reason to be optimistic regarding the
efficacy of therapeutics that interfere with Fe(III) acquisition
at early stages of infection (4, 30, 46), an understudied and
potentially important aspect of the problem is whether iron
always exists in the ferric state as infections progress, especially
as inflammation is stimulated, cell densities increase, and
oxygen tensions in CF sputum decline (78). Although the total
amount of extracellular iron can reach high values in CF spu-
tum (59), the chemical nature of this iron (e.g., free, chelated
to siderophores or some other microbial ligand, or heme) and
what fraction is oxidized or reduced is unknown. What is
known, however, is that many P. aeruginosa strains isolated
from CF sputum make redox-active phenazine compounds (21,
69), that phenazines are present in CF sputum at concentra-
tions in the 1 to 100 M range (77), and that their concentra-
tion increases as lung function declines across a broad patient
cohort (R. C. Hunter and D. K. Newman, unpublished data).
Phenazines are capable of reducing a variety of high-reduction-
potential oxidants, including Fe(III), through extracellular
electron transfer (14, 27, 28, 54, 74). In vitro experiments have
shown that phenazines can liberate Fe(III) from transferrin by
reducing it to ferrous iron [Fe(II)] (14), as well as reducing
highly insoluble Fe(III) (hydr)oxides to Fe(II) (27, 74). Thus,
there is reason to speculate that at least some fraction of the
total iron in CF sputum may be in the ferrous form and that
efforts to iron limit P. aeruginosa through Fe(III) sequestration
may be compromised by phenazine-promoted reduction of
Fe(III) to Fe(II).
Although it has long been appreciated that P. aeruginosa
may acquire iron via siderophore-independent pathways (48),
whether phenazines might play a role in iron acquisition in the
context of biofilm formation has not been studied. Here, we
sought to test the hypothesis that phenazine-mediated Fe(II)
acquisition through the ferrous iron uptake system (Feo [11,
40]) could alleviate Fe(III) limitation and stimulate biofilm
formation.
MATERIALS AND METHODS
Chemicals. Phenazine-1-carboxylate (PCA) was purified from aerobic station-
ary-phase cultures of Pseudomonas fluorescens strain 2-79 (NRRL B-15132) (70)
grown in King’s A medium (32) at 30°C, as previously described (74). Pyocyanin
(PYO) was purified from aerobic stationary-phase cultures of P. aeruginosa strain
UCBPP-PA14 (56) grown in Luria-Bertani (LB) broth at 37°C, as previously
described (74). Pyoverdine, purified according to the method described in Al-
brecht-Gary et al. (2), and pyochelin, characterized and synthesized according to
published procedures (80, 81), were provided by Schalk’s group (Institut de
Recherche de l’Ecole de Biotechnologie de Strasbourg, IREBS FRE3211 CNRS/
Universite´ de Strasbourg, France). Fe(OH)3(s), referred to as the Fe(III) min-
eral ferrihydrite, was synthesized according to the method by Schwertmann and
Cornell (66), as previously described (74). Substantially iron-free conalbumin,
1,10-phenanthroline, hydroxylamine hydrochloride, ammonium acetate, ferrous
ammonium sulfate, and carrier DNA for yeast transformation were purchased
from Sigma-Aldrich. All enzymes used for DNA manipulation were purchased
from New England BioLabs.
Strains, plasmids, primers, and growth conditions. Tables 1 and 2 list the
strains, plasmids, and primers used in this study. For planktonic and biofilm
experiments with P. aeruginosa PA14 strains, 0.3 g/liter of Bacto tryptic soy broth
(TSB; 1% TSB, where 1% is relative to the usual concentration of TSB medium
[30 g/liter]; Becton Dickinson) was used as the medium. Where indicated, for the
PA14 siderophore-null strain (pvdA pchE), 1.0 M Fe(OH)3(s), 10 M PCA
or PYO, or 1.0 M Fe(OH)3(s) together with 10 M PCA or PYO was added to
1% TSB. Also as indicated, for the PA14 wild type and the feoB::MAR2xT7
mutant (from the nonredundant PA14 mutant library [38]), 10 M PCA or PYO
alone or 40 g/ml of iron-free conalbumin alone or together with 10 M PCA or
PYO was added to 1% TSB. Flow cell biofilm experiments with the PA14 wild
type and phenazine deletion (phz) strains were also performed in 1% TSB
supplemented with 10 M PCA. To confirm that in contrast to the PA14 wild
type, the pvdA pchE strain was unable to produce pyoverdine and pyochelin
during planktonic growth, an iron-deficient morpholinepropanesulfonic acid
(MOPS)-based medium (100 mM MOPS at pH 7.2, 20 mM succinate, 93 mM
NH4Cl, 43 mM NaCl, 2.2 mM KH2PO4, and 1 mM MgSO4 [modified from
reference 50]) was used. These planktonic growth experiments were performed
in acid-washed iron-free sterile glass culture tubes or polypropylene flasks at
37°C with vigorous shaking at 250 rpm to generate aerobic conditions. To con-
firm that the PA14 feoB::MAR2xT7 mutant was disrupted in ferrous iron trans-
port, cells were incubated, with anaerobic shaking, in Amberlite-treated 1% TSB
containing 100 mM KNO3, 50 mM glutamate, 1% glycerol, and 100 M iron
source [either (NH4)2Fe(II)(SO4)2 or Fe(III)Cl3] at 37°C for 22 h. Culture
densities were monitored at an optical density at 500 nm (OD500) in a Thermo
Scientific Spectronic 20D or Shimadzu UV-2450 spectrophotometer.
P. aeruginosa PA14 strains and Escherichia coli strains used for mutant con-
struction were cultured in LB broth (Fisher Scientific) at 37°C. E. coli BW29427
and -2155 were supplemented with 0.3 mM diaminopimelic acid. The yeast
Saccharomyces cerevisiae uracil-auxotrophic strain InvSc1 (Invitrogen), used for
gap repair cloning (10, 19), was grown with yeast extract-peptone-dextrose me-
dium (YPD medium; 1% Bacto yeast extract, 2% Bacto peptone, and 2%
dextrose) at 30°C, and selections were performed with synthetic defined agar
(SDA) medium lacking uracil (URA; Qbiogene 4813-065). For selection and
maintenance of plasmids pMQ30 and its derivatives, as well as pAKN69, genta-
micin was used at 15 g/ml for E. coli and 75 to 100 g/ml for P. aeruginosa,
respectively. Selection and maintenance of E. coli containing pUX-BF13 was
carried out on 100 g/ml of ampicillin.
Strain construction. P. aeruginosa synthesizes two known siderophores, the
stronger Fe(III)-binding pyoverdine and the weaker Fe(III)-binding pyochelin
(53). We constructed the siderophore-null strain by generating unmarked dele-
tions of the pyoverdine and pyochelin biosynthetic genes pvdA (71) and pchE
(61), respectively, in PA14 wild type. Analogously, we constructed the phenazine-
siderophore-null strain in the PA14 phenazine-null strain (phz). We first de-
leted pvdA and then pchE. Here we describe the protocol for in-frame deletion
of pvdA using yeast gap repair cloning based on previously developed methods
(10, 19, 49, 67). The 5 and 3 regions (both 1 kb in length) of the sequence
flanking pvdA were amplified using primer pairs pvdAKO1/pvdAKO2 and
pvdAKO3/pvdAKO4, respectively (Table 2). These 5- and 3-flanking DNA
fragments and the gapped plasmid vector pMQ30 were simultaneously intro-
duced into the yeast S. cerevisiae uracil auxotrophic strain InvSc1 (Invitrogen) for
in vivo recombination (10, 19). The plasmid pMQ30 is an allelic exchange vector
for Gram-negative bacteria unable to support replication of the ColE1 origin and
contains CEN6/ARSH4 DNA sequences to support replication in S. cerevisiae, a
URA3 yeast-selectable marker, a multicloning site in a lacZ allele for blue-
white screening, an oriT for conjugation-mediated plasmid transfer, a gentami-
cin-resistance gene (aacC1), and the counterselectable marker sacB (67). Re-
combinant yeast cells were selected for on medium deficient in uracil. Plasmids
were liberated from recombinant yeast and electroporated into E. coli UQ950,
which was used as a host strain for plasmid replication (3). Transformants
containing recombination products of pMQ30 with the PCR products were
isolated by blue-white screening and gentamicin resistance (3), yielding the
construct for deleting the PA14 pvdA gene. This plasmid, which we call pYW01
(Table 1), was purified from E. coli UQ950, transformed by heat shock into E.
coli BW29497 (a diaminopimelic acid auxotroph), and then mobilized into PA14
(the wild type or the phz mutant) via biparental conjugation (76). PA14 (the
wild type and the phz mutant) single recombinants (merodiploid containing the
intact and the deleted pvdA gene) were isolated by selecting for gentamicin
resistance. Resolution of the merodiploid was performed by selection on 10%
sucrose, followed by PCR-based screening for loss of the wild-type gene to isolate
the pvdA deletion mutants (referred to as pvdA and phz pvdA). The deletion
of pchE from the pvdA and phz pvdA strains was performed the same way,
using primer pairs pchEKO1/pchEKO2 and pchEKO3/pchEKO4 (Table 2). Be-
sides using PCR-based diagnosis, we confirmed the pvdA pchE and phz
pvdA pchE mutants by their inability to produce pyoverdine or pyochelin
when grown in iron-deficient MOPS-based medium, in contrast to the wild-type
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and phz strains, respectively (see “Analyses of phenazines and siderophores”
for pyoverdine and pyochelin detection methods).
To follow P. aeruginosa biofilm development using confocal microscopy, we
generated YFP-labeled PA14 strains by introducing a chromosomally encoded
constitutive enhanced yellow fluorescent protein (EYFP) into the wild type,
phz, pvdA pchE, and phz pvdA pchE strains. Plasmid pAKN69, contain-
ing the mini-Tn7(Gm)PA1/04/03-eyfp fusion, was used for this purpose (35). This
plasmid was cloned into E. coli BW29427 and then mobilized into each PA14
strain via triparental mating with the helper plasmid pUX-BF13 (carrying the
transposase genes) in E. coli -2155, as described previously (6, 33). PA14
transformants with YFP constructs were selected with gentamicin and confirmed
by YFP fluorescence.
Biofilm experiments. A flow cell system was constructed for biofilm experi-
ments. The size of each flow channel was 1.5 by 4 by 34 mm; continuous flow of
1% TSB (with or without the additives detailed in the Results section) at the rate
of 3 ml/h was supplied with a Watson-Marlow peristaltic pump. The temperature
for biofilm growth was 22°C. An early-stationary-phase culture grown in 10%
TSB was diluted to an OD500 of 0.1 in biofilm control medium (1% TSB). Each
flow cell was then inoculated with 300 l of the diluted culture by injection with
a 1-ml syringe. In order to allow cells to attach to the glass surface, the flow was
arrested for 1.5 h and then resumed throughout the length of each experiment
(up to 6 days).
To image biofilms, confocal laser scanning microscopy (CLSM) with a Leica
TCS SPE inverted microscope was used. For PA14 strains constitutively express-
ing EYFP (the wild type, phz, pvdA DpchE, and phz pvdA pchE strains),
three-dimensional fluorescence images were acquired using an excitation wave-
length of 488 nm with constant intensity and collecting emissions in the range of
510 to 618 nm. For the PA14 feoB::MAR2xT7 mutant, images were obtained
using differential interference contrast (DIC) mode. To ensure images used for
comparisons of biofilm formation were representative and reproducible, multiple
fields of view were acquired over time with a 10 dry lens objective in each flow
cell within a single experimental set, and at least four independent experimental
sets were performed. Fluorescence and DIC images were processed using
Bitplane Imaris and NIH ImageJ software. In most cases, fluorescence-based
multiple biofilm image stacks (spaced 1 to 2 m apart) were analyzed using
AutoCOMSTAT software, a modified version of the COMSTAT biofilm
TABLE 1. Strains and plasmids used in this study
Strain or plasmid Propertiesa Reference or sourceb
Strains
P. aeruginosa
PA14 Clinical isolate UCBPP-PA14; wild-type strain 56
PA14 phz PA14 with deletions of operons phzA1-G1 and phzA2-G2 17
PA14 pvdA pchE PA14 with deletions of pvdA and pchE This study
PA14 phz pvdA pchE PA14 with deletions of pvdA, pchE, and operons phzA1-G1 and phzA2-G2 This study
PA14-YFP PA14 constitutively expressing YFP from a Tn7 insertion created by
introducing plasmid pAKN69
L. E. P. Dietrich, MIT
PA14 phz-YFP PA14 phz constitutively expressing YFP; analogous to PA14-YFP L. E. P. Dietrich, MIT
PA14 pvdA pchE-YFP PA14 pvdA pchE constitutively expressing YFP plasmid pAKN69 This study
PA14 phz pvdA pchE-YFP PA14 phz pvdA pchE constitutively expressing YFP plasmid pAKN69 This study
PA14 feoB::MAR2T7 PA14 mutant with an insertion of the MAR2T7 transposon in the
PA14_56680 ORF, which is the homolog of the PAO1 ORF PA4358
38
E. coli
UQ950 DH5 	 pir host for cloning D. P. Lies, Caltech
BW29427 Donor strain for conjugation W. M. Metcalf, UIUC
-2155 Donor strain for conjugation 15
S. cerevisiae Ura
 for gap repair cloning Invitrogen
InvSC1
Plasmids
pMQ30 Yeast-based allelic exchange vector, sacB, CEN6/ARSH4, URA3, Gmr 67
pUX-BF13 R6K replicon-based helper plasmid providing the Tn7 transposition
functions in trans; can replicate only when the pir gene is supplied in
trans; Ampr
6
pAKN69 Transposon delivery plasmid containing the mini-Tn7(Gm)PA1/04/03::eyfp
fusion
35
pYW01 pvdA deletion fragments cloned into pMQ30 This study
pYW02 pchE deletion fragments cloned into pMQ30 This study
a ORF, open reading frame.
b UIUC, University of Illinois at Chicago.
TABLE 2. PCR primers used in this study
Primer Sequence (5 to 3)
pvdAKO1..........................CCA GGC AAA TTC TGT TTT ATC AGA CCG CTT CTG CGT TCT GAT AGC GCT GGA ACT CGC CAC
pvdAKO2..........................GCT TCA GGT GCT GGT ACA GTG CCT GAG TCA TTT CCA GTT CC
pvdAKO3..........................GGA ACT GGA AAT GAC TCA GGC ACT GTA CCA GCA CCT GAA GC
pvdAKO4..........................GGA ATT GTG AGC GGA TAA CAA TTT CAC ACA GGA AAC AGC TCT GAA GCC GAT GTT GAC CAC
pchEKO1..........................CCA GGC AAA TTC TGT TTT ATC AGA CCG CTT CTG CGT TCT GAT CTG ATC CTC GTG CAG AGC
pchEKO2..........................GGT CTG CAC CTG CAA GTG CAG GGC GGT ACG GGA ATC
pchEKO3..........................GAT TCC CGT ACC GCC CTG CAC TTG CAG GTG CAG ACC
pchEKO4..........................GGA ATT GTG AGC GGA TAA CAA TTT CAC ACA GGA AAC AGC TCG TCA GGT TGA GAC AGA ACG
3608 WANG ET AL. J. BACTERIOL.
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evaluation package by Heydorn et al. (29, 44). For each image, a global thresh-
old was calculated using the robust automated threshold selection algorithm with
a critical-size setting of 20 m, and connected volume filtering was performed
with a connectivity setting of 18 to remove free-floating biomasses. Substratum
coverage calculations were based on the first 3 m above the substratum. The
area of each analyzed image was 3.03 105 m2. The results from measurements
of one to six images for each strain and treatment were averaged, and the
standard error of the mean was calculated. The biofilm parameters reported here
are biovolume per image area (referred to as biomass), substratum coverage,
maximum height, and average height of the biomass, which excludes any area not
covered by cells.
Iron analysis. The total concentrations of iron in TSB-based media and sus-
pensions of the mineral ferrihydrite were analyzed by the phenanthroline assay
according to published protocols (34). In summary, complete reduction of
Fe(III) (soluble and/or mineral forms) to soluble Fe(II) was achieved by adding
the reductant hydroxylamine hydrochloride to acidified samples. 1,10-Phenan-
throline and the pH buffer ammonium acetate were then added and allowed
enough time to fully develop an orange-red Fe(II)-phenanthroline complex at
pH 3.5. The total iron concentrations reflected by the colored Fe(II) complex
were calculated based on the absorbance readings at 510 nm in a Shimadzu
UV-2450 spectrophotometer. Iron in sterile, aerobic, TSB-based media should
be present as the oxidation state 3, even though the specific Fe(III) forms are
unknown.
Analyses of phenazines and siderophores. Filtrates (passed through a 0.2-m-
pore-size filter) were prepared from biofilm effluents or planktonic cultures. For
characterizing and quantifying phenazines and the siderophore pyochelin,
filtrates were directly loaded onto a Beckman System Gold reverse-phase
high-pressure liquid chromatography (HPLC) instrument with a diode array
UV-visible light (Vis) detector and a Waters Symmetry C18 analytical column
(5-m-particle size; 4.6 by 250 mm). Analysis was performed in a gradient of
water–0.1% trifluoroacetic acid (TFA; solvent A) to acetonitrile–0.1% TFA
(solvent B) at a flow rate of 1.0 ml/min using the following method. For 0 to 1
min, chromatography was performed in a linear gradient from 100% solvent A to
15% solvent B, for 1 to 12 min in a linear gradient to 58% solvent B, for 12 to
13 min in a linear gradient to 70% solvent B, for 13 to 25 min in a linear gradient
to 85% solvent B, for 25 to 26 min in a linear gradient to 100% solvent A, and
for 26 to 29 min in 100% solvent A. Phenazines (e.g., PCA, PYO, phenazine-1-
carboxamide [PCN], and 1-hydroxyphenazine [1-OHPHZ]) and pyochelin, which
are known to be potentially produced by P. aeruginosa, can all be detected based
on their characteristic absorption wavelengths and retention times as long as
their concentrations are higher than 0.05 to 0.1 M (17, 43, 65, 74).
The same HPLC instrument was used for analyzing the siderophore pyover-
dine, with gradient profiling and sample preparation as described in detail by
Bultreys et al. (9). In summary, filtrates with Fe(III)-chelated pyoverdine(s) at
pH 5.0 were prepared for HPLC by adding FeCl3 into the samples, followed by
filtration (0.2-m-pore-size filter) and pH adjustment. Analysis was carried out
in a gradient profiling with solvent A as water–17 mM NaOH–acetic acid at pH
5.0 and solvent B as acetonitrile (solvent B) (9). For samples with pyoverdine
being released at concentrations higher than 0.1 M, a single Fe(III)-pyoverdine
peak was detected at 403 nm. In addition, iron-free pyoverdine in filtered (0.2-
m-pore-size filter) biofilm effluents was analyzed using a fast fluorescence-
based method by a BioTek Synergy 4 fluorescence plate reader with a xenon flash
light source at the specific excitation/emission wavelength set of 405 nm/455 nm
(20). Control experiments and independent HPLC analyses confirmed that the
measured fluorescence signal was contributed predominantly by pyoverdine and
hence can be used for its detection and quantification.
RESULTS
PCA can work together with the siderophore pyoverdine in
promoting biofilm development. We first followed biofilm de-
velopment in the P. aeruginosa PA14 wild type, a phenazine-
null strain (phz), a siderophore-null strain (pvdA pchE),
and a phenazine-siderophore-null strain (phz pvdA pchE)
under a flow of 1% TSB medium over 4 days. In addition, we
used AutoCOMSTAT software to analyze biofilm images for
quantitative comparisons. As illustrated in Fig. 1, wild-type
biofilm formation proceeded in the typical stages such that
bacteria initially attached to the abiotic glass surface had by
day 1 clustered into microcolonies, which enlarged over time
and eventually matured by day 4. The phz mutant, despite
initially attaching equally well, formed fewer and smaller mi-
crocolonies over time than the wild type, as was seen before in
LB-based medium (57). The pvdA pchE and phz pvdA
pchE mutants showed equally severe biofilm defects and
failed to develop microcolonies even 4 days after initial attach-
ment (Fig. 1A). More quantitatively, the wild-type biomass was
only marginally higher than those of three other strains at day
1, but by day 4 was about 3 to 4 times greater than that of phz
and 40 to 60 times greater than those of the pvdA pchE and
phz pvdA pchE strains (Fig. 1B; Table 3). By day 4, the
difference in total biomass between the wild-type and phz
mutant biofilms reflected variation mainly in thickness. On the
other hand, the biofilm thickness observed for the pvdA
pchE and phz pvdA pchE strains was about the same as
that of the phz strain; their extremely low total biomass re-
sults primarily from a lack of surface coverage (Table 3).
To further correlate phenazine and/or siderophore pro-
duction with biofilm development, we simultaneously ana-
lyzed the compounds being released into the biofilm efflu-
ents for the wild type and the phz and pvdA pchE strains
(Fig. 1C). The wild type started to release measurable levels of
PCA (the precursor phenazine produced by all phenazine-
making pseudomonads [43, 54]) and the siderophore pyover-
dine beginning on day 2. Concomitant with biofilm develop-
ment, both PCA and pyoverdine concentrations increased with
time, with a dramatic rise in the PCA concentration by day 4.
Surprisingly, no other phenazines, including the blue-colored
PYO, ever reached concentrations above their respective
HPLC detection limits (0.05 to 0.1 M) under our biofilm
growth conditions. Given that PYO is a highly diffusible zwit-
terion at circumneutral pH, we interpret the absence of PYO
in the biofilm effluents to reflect little or no production rather
than its retention in the biofilm matrix. The phz mutant
started to release a measurable level of pyoverdine on day 2,
and the pyoverdine concentration increased along with biofilm
development. Despite releasing more pyoverdine than the wild
type, the phz mutant generated 3 to 4 times less biofilm
biomass by day 4. Adding 10 M PCA (comparable to the
levels detected in wild-type day 4 biofilm effluents) to the
medium of the phz mutant throughout the experimental
timescale increased the biofilm biomass 4 times by day 6, re-
sulting in a biomass similar to that of the wild type (Fig. S1).
The pvdA pchE mutant that failed to form biofilms did not
release phenazines until day 4, and even then only at trace
levels. Because phenazines are typically released only at a high
cell density due to quorum-sensing regulation (17, 54), the lack
of phenazine production by this strain in light of its sparse
growth is not surprising. The lack of phenazine production by
the pvdA pchE strain matches our observation that the
pvdA pchE and phz pvdA pchE strains show equally
severe biofilm defects. Collectively, these data indicate that
both siderophores and phenazines (particularly PCA under
these conditions) promote biofilm formation.
PCA can promote biofilm formation by generating Fe(II) in
the absence of siderophores. It is well established that pyover-
dine promotes P. aeruginosa biofilm formation by facilitating
iron acquisition (5). Effective iron acquisition is essential for
biofilm development because more iron is required than for
planktonic growth (68). This is due to the fact that iron acts as
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a signal to trigger the transition from a motile to a sessile state
(68). From the phenanthroline assay, we calculated the total
iron concentration to be 0.2 M in 1% TSB. Because the
medium was prepared aerobically at pH 7, the oxidation state
of iron originally present in the medium should be 3, even
though the specific Fe(III) forms are unknown. It is commonly
believed that bioavailable iron in the micromolar concentra-
tion range is required for optimal bacterial growth (53, 58), and
hence the iron content in 1% TSB verges on the lower thresh-
old. If the observed PCA-promoted biofilm formation (Fig. 1)
were due to a stimulation in iron acquisition as a result of
phenazine-facilitated Fe(III) reduction to Fe(II), we would
FIG. 1. The phenazine PCA can work together with the siderophore pyoverdine in promoting P. aeruginosa biofilm formation. (A) Confocal
microscopic images of biofilms at day 4 (A), total biomass over time as inferred by Auto-COMSTAT analysis (B), and the corresponding release
of phenazine(s) and/or siderophore(s) into the biofilm effluents for the YFP-labeled PA14 wild type (WT), the phenazine-null strain (phz), the
siderophore-null strain (pvdA pchE), and the phenazine-siderophore-null strain (phz pvdA pchE) under a flow of 1% TSB medium at 22°C
(C) are shown. Confocal images consist of top-down views (x-y plane, top images) and side views (x-z plane, bottom images, enlarged and truncated
to emphasize differences in the z dimension). Results are representative of six experiments. Data reported in panels B and C represent means 
standard errors of the means (SEMs). Related quantitative data can be found in Table 3. Scale bars, 100 m for images with a top-down view and
50 m for side-view images.
TABLE 3. Quantitative analyses of flow cell biofilms formed by P. aeruginosa PA14 strainsa
Day PA14 strain No. ofimages
Total biomass
(m3/m2)
Substratum
coverage (%)
Avg thickness of
biomass (m)b
Maximum biofilm
thickness (m)
1 WT 6 0.83  0.11 7.1  0.8 13.2  0.4 40
phz 6 0.18  0.03 1.9  0.3 11.3  0.8 35
pvdA pchE 6 0.38  0.08 4.5  0.9 10.8  0.4 28
phz pvdA pchE 6 0.59  0.08 5.7  0.9 13.0  0.6 37
2 WT 5 2.54  0.41 14.0  1.0 19.9  3.4 89
phz 6 1.04  0.15 10.0  0.9 13.0  1.9 60
pvdA pchE 6 0.50  0.08 4.5  0.7 12.2  0.2 33
phz pvdA pchE 6 0.79  0.13 6.3  0.8 13.4  0.5 31
4 WT 3 8.10  0.75 28.1  0.6 28.9  3.0 95
phz 4 2.37  0.26 23.1  3.3 13.8  0.7 44
pvdA pchE 2 0.20  0.09 1.5  0.1 13.8  4.3 47
phz pvdA pchE 4 0.13  0.05 1.0  0.3 14.0  0.9 36
a Biofilms were formed under a flow of 1% TSB medium at 22°C for 4 days. Representative images from this data set are shown in Fig. 1. All values are means of
the results of n images  the standard error of the mean. Each image covers an area of 3.03  105 m2. WT, wild type.
b Calculated for the area covered by the biomass.
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expect that PCA would be able to circumvent the pyoverdine
pathway if enough Fe(III) were provided. To test whether PCA
could rescue the biofilm defect in the PA14 pvdA pchE
mutant in the presence of sparingly soluble Fe(III), we inves-
tigated the effect of adding 1.0 M ferrihydrite mineral sus-
pension [Fe(OH)3(s); Ksp [the solubility product constant] 
10
38.8 M (47)] alone, 10 M PCA alone, or 1.0 M
Fe(OH)3(s) together with 10 M PCA to the base medium
(1% TSB). Adding exogenous PCA was necessary because,
unlike the wild type, the pvdA pchE strain produced very
little PCA on its own (Fig. 1C). We found that adding
Fe(OH)3(s) or PCA alone could not rescue biofilm formation
by the pvdA pchE mutant strain with statistical significance
(Fig. 2; Table 4). By contrast, when Fe(OH)3(s) and PCA were
added together, dramatic rescue was observed (Fig. 2; Table
4). This is consistent with our prior abiotic experiments which
showed that some phenazines, including reduced PCA, can
promote Fe(OH)3(s) reduction over a broad pH range and
liberate bioavailable Fe(II) (27, 74). The fact that adding PCA
to 1% TSB can promote biofilm formation by the phz mutant
(which makes pyoverdine but not phenazines) but not the
pvdA pchE mutant (which cannot make pyoverdine and is
severely delayed in producing phenazines; Fig. 1C) further
supports the conclusion that PCA and pyoverdine both con-
tribute to biofilm formation. However, even in the absence of
pyoverdine, PCA-promoted rescue can be achieved by adding
just 1 M Fe(III) to the base medium with 0.2 M total Fe
(Fig. 2; Table 4). This rescue occurred even with the total iron
concentration (1.2 M) being more than 10 times lower than
that reported in CF sputum (generally greater than 10 M,
ranging from 17 to 200 M) (60). Therefore, PCA can stimu-
late P. aeruginosa biofilm formation in the presence of other-
wise biologically unavailable Fe(III), even in the absence of
pyoverdine if sufficient iron levels can be attained.
PCA can promote biofilm formation in the presence of
conalbumin by facilitating Fe(II) uptake. The previous exper-
iments used the effectively insoluble mineral ferrihydrite to
limit cells for Fe(III). While this may be relevant to under-
standing Fe(III) acquisition by P. aeruginosa in soil environ-
ments, in a clinical context, Fe(III) limitation results from
binding by host-produced proteins of the transferrin family
(including lactoferrin, serotransferrin, and conalbumin; Kd
[dissociation constant]  1020 to 23 M
1) (1, 58). We note,
FIG. 2. PCA and PYO can circumvent the siderophore pathway for
promoting P. aeruginosa biofilm development via Fe(II) uptake-depen-
dent and -independent mechanisms, respectively. The effectively insol-
uble Fe(III) mineral ferrihydrite [Fe(OH)3(s)] was the Fe(III) source.
Confocal microscopic images of the YFP-labeled P. aeruginosa PA14
siderophore-null strain (pvdA pchE) incubated in biofilm flow cells
at 22°C for 6 days with no additions or with the addition of 1.0 M
Fe(OH)3(s), 10 M phenazine (PCA or PYO), or 1.0 M Fe(OH)3(s)
together with 10 M phenazine (PCA or PYO) to 1% TSB medium.
Images are top-down views (x-y plane). Results are representative of
four experiments. Related quantitative data can be found in Table 4.
Scale bar, 100 m.
TABLE 4. Quantitative analyses of flow cell biofilms formed by the P. aeruginosa PA14 pvdA pchE-YFP straina
Day Additive(s) to biofilmcontrol medium (1% TSB)
No. of
images
Total biomass
(m3/m2)
Substratum
coverage (%)
Avg thickness of
biomass (m)b
Maximum biofilm
thickness (m)
2 None ND
1.0 M Fe(OH)3(s) 4 0.03  0.00 0.4  0.1 10.7  2.0 30
10 M PCA 4 0.05  0.01 0.6  0.2 12.6  1.4 32
1.0 M Fe(OH)3(s), 10 M PCA 4 0.45  0.21 6.3  3.3 11.1  1.2 30
10 M PYO 3 0.09  0.03 0.8  0.3 13.5  0.4 34
1.0 M Fe(OH)3(s), 10 M PYO 4 0.57  0.29 7.3  3.7 10.3  0.5 34
4 None ND
1.0 M Fe(OH)3(s) 3 0.05  0.01 0.5  0.2 12.1  2.3 30
10 M PCA 4 0.19  0.09 2.9  1.4 10.8  0.9 34
1.0 M Fe(OH)3(s), 10 M PCA 4 1.90  1.08 12.5  6.4 15.8  1.8 44
10 M PYO 4 0.83  0.22 9.9  2.4 10.1  0.4 42
1.0 M Fe(OH)3(s), 10 M PYO 4 3.1  1.76 19.2  9.2 10.8  2.4 48
6 None 4 0.63  0.16 6.0  1.0 10.4  0.8 40
1.0 M Fe(OH)3(s) 4 0.75  0.33 3.3  1.3 24.3  1.6 82
10 M PCA 3 0.21  0.09 3.3  2.1 16.1  4.4 66
1.0 M Fe(OH)3(s), 10 M PCA 4 4.87  1.32 29.3  8.5 18.9  1.8 80
10 M PYO 3 9.54  0.18 44.3  5.1 24.1  2.1 94
1.0 M Fe(OH)3(s), 10 M PYO 3 4.20  0.17 31.8  3.5 19.9  2.6 56
a Biofilms were formed at 22°C for 6 days with no addition or with the addition of 1.0 M Fe(OH)3(s), 10 M phenazine (PCA or PYO), or 1.0 M Fe(OH)3(s)
together with 10 M phenazine (PCA or PYO) to 1% TSB medium. Representative day 6 images from this data set are shown in Fig. 2. All values are means of the
results for n images  the standard error of the mean. Each image covers an area of 3.03  105 m2. ND, not determined.
b Calculated for the area covered by the biomass.
VOL. 193, 2011 PCA PROMOTES BIOFILM DEVELOPMENT VIA Fe(II) ACQUISITION 3611
 o
n
 M
arch 11, 2013 by CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y
http://jb.asm.org/
D
ow
nloaded from
 
however, that recent studies have documented formation of
nanoparticles of Fe(III) (hydr)oxides on human serum trans-
ferrin fibrils (22), so the two may not be as distinct as previ-
ously thought. Regardless, it has been suggested that the
Fe(III)-sequestering function of lactoferrin presents an innate
defense against P. aeruginosa; by competing against high-affin-
ity siderophore(s) for binding Fe(III), a subinhibitory concen-
tration of lactoferrin that does not impose a planktonic growth
defect prevents P. aeruginosa from accessing the level of iron
required to signal the transition to the biofilm mode of growth
(5, 68). Furthermore, earlier experiments performed with
whole-bacterial-cell suspensions showed that PYO could me-
diate Fe(II) uptake by iron-limited P. aeruginosa by reducing
transferrin-bound Fe(III) with concomitant liberation of
Fe(II), due to its much weaker affinity for Fe(II) (103 M
1)
(58). This led us to hypothesize that PCA could stimulate
biofilm development by facilitating Fe(II) uptake through re-
ductive liberation of Fe(II) from host Fe(III)-binding proteins,
a pathway that is independent of siderophore-mediated Fe(III)
uptake.
To test this hypothesis, we compared biofilm development un-
der a flow of 1% TSB between the wild type and the
feoB::MAR2xT7 mutant, a strain disrupted in gene PA14_56680,
which encodes the cytoplasmic membrane protein FeoB (11,
40). We confirmed the identity of this mutant by sequencing
and performing a diagnostic phenotypic test, as follows. Be-
cause FeoB was recently shown to be the transporter required
for energy-dependent Fe(II) uptake across the cytoplasmic
membrane of P. aeruginosa (11, 40), distinct from the more
extensively studied TonB1-dependent ABC transport system
for siderophore-mediated Fe(III) uptake (53, 64, 82), we pre-
dicted that the feoB::MAR2xT7 mutant would not grow on
Fe(II). To test this prediction, we performed experiments in
iron-free medium to which we added back either Fe(II) or
Fe(III). As expected, the feoB::MAR2xT7 mutant could not
grow anaerobically in planktonic batch cultures when given
Fe(II) as its sole iron source, yet it could grow in the presence
of Fe(III); under the same conditions, the wild type grew
regardless of whether iron was in the ferric or ferrous form
(Fig. 3). In 1% TSB medium, both strains developed into
mature biofilms over time, as expected (Fig. 4B). However,
when we reduced the amount of available iron by adding the
iron chelator conalbumin (in its iron-free form), neither strain
formed biofilms. Previous researchers have also used conalbu-
min as a lactoferrin surrogate in these types of experiments
(45, 68) because they have similar structures, Fe(III)-binding
capacities, and effects on biofilm formation. To confirm that
the amounts of conalbumin and PCA used in our biofilm ex-
periments specifically affected the amount of iron required to
signal biofilm formation and not the amount of iron required
for planktonic growth, we measured planktonic growth by the
wild type and the feoB::MAR2xT7 mutant; the additive(s) had
no effect on the growth of either strain (Fig. 4A). When we
added both conalbumin and PCA, making the acquisition of
sufficient iron to signal biofilm formation dependent upon
PCA-mediated reduction of conalbumin-bound Fe(III) to
Fe(II), the wild type could form biofilms but the
feoB::MAR2xT7 mutant could not.
For both the wild type and the feoB::MAR2xT7 mutant, in
contrast to the mature biofilms formed in medium without
additives, in medium with added conalbumin, attached bacte-
ria mostly remained as separated individual cells and failed to
form clusters even after 6 days (Fig. 4B). This is similar to what
was observed by other investigators studying P. aeruginosa
strain PAO1 in the presence of lactoferrin (5, 30, 68). In accord
with the conalbumin-induced severe biofilm defect, little PCA
was released into the biofilm effluents by either strain ( 0.05
to 0.1 M), as expected for density-dependent phenazine pro-
duction (17, 54). For the wild type, the addition of PCA to
conalbumin-treated medium rescued the defect by promoting
biofilm growth into a uniformly distributed lawn type structure,
distinct from the mushroom-like structures observed in control
medium (Fig. 4B), within 6 days. With PCA-induced rescue, by
day 6, the biofilm biomass increased by a factor of 13 compared
to biofilms treated with conalbumin alone; the total biofilm
biomass was comparable to that in medium without additives
(Table 5). The wild-type biofilm developed similarly with re-
spect to structure and biomass regardless of whether PCA was
added to the control medium (data not shown), indicating that
PCA-induced rescue was specific to the biofilm defect caused
by the conalbumin treatment. On the other hand, for the
feoB::MAR2xT7 mutant with a disrupted Fe(II) transporter,
PCA addition failed to rescue the conalbumin-induced biofilm
defect (Fig. 4B). Together, these results indicate that PCA’s
ability to rescue biofilm formation in the presence of the
Fe(III)-binding protein conalbumin is due to the fact that it
makes Fe(II) bioavailable by reducing protein-sequestered
Fe(III) through extracellular electron transfer.
The phenazine PYO can affect biofilm formation indepen-
dently of facilitating Fe(II) uptake. PYO, a well-studied phen-
azine produced by P. aeruginosa and also detected in CF spu-
tum (77), has been previously shown to affect biofilm
formation in LB-based medium (57). Even though PYO was
not released under our 1% TSB-based biofilm medium condi-
tions, we performed analogous experiments to examine
whether PYO might promote biofilm development in the same
FIG. 3. The P. aeruginosa PA14 feoB::MAR2xT7 mutant (feoB::tn)
cannot grow when given Fe(II) as its sole iron source, yet it can grow
in the presence of Fe(III); the wild type (WT) can grow regardless of
whether iron is in the ferric or ferrous form. Cells were incubated, with
anaerobic shaking, in Amberlite-treated 1% TSB medium contain-
ing100 mM KNO3, 50 mM glutamate, 1% glycerol, and 100 M iron
source [either (NH4)2Fe(II)(SO4)2 or Fe(III)Cl3] at 37°C for 22 h.
Data reported are the means of triplicate experiments  standard
deviations (SDs).
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manner as PCA. We first tested whether PYO could rescue the
biofilm defect in the PA14 pvdA pchE mutant by comparing
the effect of adding 10 M PYO alone to the effect of adding
1.0 M Fe(OH)3(s) and 10 M PYO together to the base
medium (1% TSB). In contrast to PCA’s rescue occurring only
together with the addition of 1.0 M Fe(OH)3(s), PYO res-
cued the biofilm defect regardless of whether Fe(OH)3(s) was
present; the rescue without Fe(OH)3(s) was 2 times greater
than that with the addition of Fe(OH)3(s) (Fig. 2; Table 4).
We next tested whether the addition of PYO to conalbumin-
treated 1% TSB medium could rescue the PA14 wild-type
biofilm defect. Unlike PCA, PYO did not rescue the conalbu-
min-induced biofilm defect when added to the medium (Fig.
4B; Table 5). This implies that PYO cannot efficiently reduce
conalbumin-bound Fe(III) under these conditions, which is
consistent with PYO being a thermodynamically less favorable
reductant than PCA (74). However, this result was somewhat
unexpected, given an earlier study by Cox that reported that P.
aeruginosa could reduce transferrin-bound Fe(III) (14). We
speculate that the reason PYO did not stimulate conalbumin-
bound Fe(III) reduction for us, but did stimulate transferrin-
bound Fe(II) reduction for Cox, is that one or more of the
following caveats apply: (i) even though proteins within the
transferrin family (such as conalbumin and transferrin) have
FIG. 4. (A) The presence of subinhibitory levels of conalbumin alone or together with phenazine (PCA or PYO) does not inhibit planktonic
growth of P. aeruginosa PA14 strains. Experiments were performed in batch cultures in 1% TSB-based biofilm medium at 37°C. Data reported are
the means of triplicate experiments  SDs. (B) PCA but not PYO can rescue the conalbumin-induced P. aeruginosa biofilm defect by reducing
protein-sequestered Fe(III) with concomitant release of Fe(II). Shown are confocal microscopic images of YFP-labeled P. aeruginosa PA14 wild
type (WT) and DIC microscopic images of the P. aeruginosa PA14 feoB::MAR2xT7 mutant (feoB::tn) disrupted in Fe2 transport into the cytoplasm
and incubated in biofilm flow cells at 22°C for 6 days, with no addition or with the addition of 40 g/ml of iron-free conalbumin alone or together
with 10 M phenazine (PCA or PYO) to 1% TSB medium. Confocal images consist of top-down views (x-y plane, top images) and side views (x-z
plane, bottom images, enlarged and truncated to emphasize differences in the z dimension). DIC images are top-down views (x-y plane). Results
are representative of four experiments. Related quantitative data can be found in Table 5. Scale bars, 100 m for images with top-down views and
50 m for side-view images.
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similarly strong Fe(III)-binding capacities, the Kd values can be
different by 2 to 3 orders of magnitude (1); (ii) a given
phenazine’s Fe(III) reduction activity depends on factors such
as concentration ratios between reactants [e.g., phenazine ver-
sus chelated Fe(III)] and/or the presence of other oxidants that
could react more readily with reduced phenazines. For exam-
ple, reduced PYO has been shown to be much more reactive
toward oxygen than reduced PCA, making PYO more subject
to oxygen competing with Fe(III) as an electron acceptor (74).
Consistent with this, in the whole bacterial cell suspension
system studied by Cox, PYO was demonstrated to be efficient
at reducing transferring-bound Fe(III) only under a strict an-
aerobic condition (14). Considering that our flow cell biofilm
system is very different from the one studied by Cox both with
respect to oxygen content and other factors, it makes sense that
phenazine reactivity would be different. Interestingly, PYO did
not stimulate iron-independent rescue under these conditions
either, in contrast to what we observed for the pvdA pchE
mutant under different iron-limited conditions (Fig. 2).
DISCUSSION
Phenazines can affect cells in multiple ways, ranging from
deleterious (generating toxic superoxide species; see refer-
ences 26, 36, 37, and 39) to beneficial (serving as signaling
molecules that foster biofilm development [18] and promote
redox homeostasis [55] and survival when oxidants are limited
[73]). To this list we now add another function: the potential
for phenazines to enhance biofilm formation by making iron
more available. While it is well known that all organisms need
iron to grow, it has become clear that an amount of iron in
excess of this need is required for biofilm formation (5, 7, 51,
62, 68). In this context, more attention has been placed on
ferric iron acquisition by P. aeruginosa than on ferrous iron
acquisition (59); however, our results suggest that the latter
might be important in environments where phenazines are
present, ranging from the rhizosphere (24) to the CF lung (13).
Here we have shown that in the presence of Fe(III) and the
phenazine PCA, biofilm formation can proceed in the absence
of siderophores and in the presence of host iron-binding pro-
teins such as conalbumin. While we have focused on the elec-
tron-shuttling properties of the phenazine PCA in this study,
we note that similar iron acquisition mechanisms have been
proposed for phenazine-like riboflavin produced by Shewanella
species (41) and Helicobacter pylori (79) and for humic-like
pyomelanin produced by Legionella pneumophila (12), al-
though these have not been tested in biofilm systems.
By highlighting the importance of phenazines in changing
the redox state of iron, we do not mean to imply that other
means of iron acquisition are somehow less essential for P.
aeruginosa. On the contrary, it is well established that sidero-
phore production is crucial for Fe(III) acquisition by P. aerugi-
nosa (as well as many other bacteria) and that this is necessary
for their growth in many contexts. Moreover, we hasten to
point out that phenazine production is relevant for P. aerugi-
nosa only once it has achieved a sufficiently high density for
phenazine biosynthesis to be initiated. What we suggest is that
the relative importance of different types of iron acquisition
strategies likely change over time in response to changes in the
chemistry of the microenvironment that P. aeruginosa and
other bacteria inhabit. In environments where iron is primarily
in the ferric form, growth of P. aeruginosa necessitates sidero-
phores. However, as cultures grow in cell density, inflammation
progresses, and phenazine production begins, siderophores
would be expected to decline in importance for iron acquisition
as phenazines mediate the reduction of Fe(III) to Fe(II)
and/or heme becomes more available. Consistent with this, we
have observed that one of the major effects of phenazine pro-
duction at the transcriptional level is the repression of genes
involved in Fe(III) acquisition (e.g., downregulation of sidero-
phore biosynthesis and transport) (18). While for the sake of
clarity we genetically separated siderophore from phenazine
production in this study, in the wild type, both siderophores
and phenazines contribute to iron acquisition: siderophores
play a role early in biofilm development, but likely become less
important once phenazine production begins.
Regardless of how Fe(III) is bound—be it in the form of
insoluble ferric (hydr)oxides or chelated to host proteins—it is
susceptible to reductive liberation to Fe(II) by reacting with
phenazines, rendering it more bioavailable to P. aeruginosa
(Fig. 5). Our results suggest that reduced PCA can efficiently
reduce host protein-bound Fe(III) even though, paradoxically,
this is predicted to be thermodynamically unfavorable at pH 7:
the redox potentials for Fe(III)/Fe(II) and PCA (oxidized ver-
sus reduced) redox pairs are reported as 
500 mV (52) and

116 mV (74), respectively. Note that these numbers corre-
spond to equilibrium conditions, which likely are quite differ-
ent from those within a biofilm. For example, biofilms are
known to experience oxygen limitation (28), which would shift
the redox equilibrium of PCA toward its reduced form. In
addition, Fe(II) librated by reducing Fe(III) can be taken up by
cells. Both of these effects would drive redox reactions between
host protein-bound Fe(III) with reduced PCA in a more ther-
modynamically favorable direction.
TABLE 5. Quantitative analysis of flow cell biofilms formed by WT P. aeruginosa PA14 with different additives by day 6a
Additive(s) to biofilm
control medium (1% TSB)
No. of
images
Total biomass
(m3/m2)
Substratum
coverage (%)
Avg thickness of
biomass (m)b
Maximum biofilm
thickness (m)
None 1 7.20 46.7 16.4 62
40 g/ml conalbumin 6 0.80  0.08 11.8  1.3 9.0  0.7 32
40 g/ml conalbumin, 10 M PCA 4 10.70  0.49 80.0  4.3 13.2  0.8 36
40 g/ml conalbumin, 10 M PYO 1 0.34 4.2 8.7 32
a Biofilms were formed at 22°C for 6 days with no addition or with the addition of 40 g/ml conalbumin alone or together with 10 M phenazine (PCA or PYO)
to 1% TSB medium. Representative day 6 images from this data set are shown in Fig. 4B. All values are means of the results for n images  the standard error of the
mean. Each image covers an area of 3.03  105 m2.
b Calculated for the area covered by the biomass.
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Given their high redox potentials, ferric (hydr)oxides can be
easily reduced by PCA even under equilibrium conditions. This
has broad relevance, given that PCA is the precursor phen-
azine produced by all phenazine-making pseudomonads (43,
54). Other natural phenazines, such as PCN and 1-OHPHZ,
can react with Fe(III) at rates comparable to that of PCA (74).
Interestingly, however, PYO is the one phenazine whose ability
to reduce Fe(III) is poor (74). We therefore think it is unlikely
that the observed PYO-enhanced biofilm rescue of our sidero-
phore mutant in the presence of Fe(OH)3(s) was due to more
efficient iron reduction under these conditions than that
achieved by PCA. In fact, PYO is known to be a signaling
molecule that helps coordinate P. aeruginosa biofilm develop-
ment (18, 57). Thus, PYO’s enhancement of biofilm formation
under these conditions could be due to an iron-independent
mechanism. Curiously, the enhancement of biofilm formation
observed in the presence of PCA plus Fe(OH)3 or PYO plus
Fe(OH)3 was less than that achieved in the presence of PYO
alone (Table 4). This suggests that PCA- or PYO-mediated
iron reduction is a double-edged sword: while it can promote
biofilm formation relative to that achieved in the presence of
Fe(OH)3 alone, it can also exact a toxic price. The detailed
mechanisms by which different phenazines affect biofilm for-
mation remain to be elucidated, but what is clear is that dif-
ferent phenazines can affect biofilm formation in different ways
under different environmental conditions.
Although it has long been recognized that the microbial
community that forms in CF sputum is complex (25), what
controls the structure and dynamics of this population is un-
clear. While many factors can be anticipated to impact the
ecological success of different species in the lung, one impor-
tant parameter is competition for iron (59). In coculture ex-
periments pitting Staphylococcus aureus against P. aeruginosa,
it was found that in the presence of S. aureus, P. aeruginosa
decreased transcription of genes known to be regulated by iron
availability (42). It was concluded that this effect was most
likely due to lysis of S. aureus by P. aeruginosa, leading to iron
release. While the iron source was not identified in this study,
one reasonable possibility is heme, which is thought to be an
important nutrient for Pseudomonas and other bacteria in CF
sputum, particularly as inflammation progresses (31, 48, 72). In
contrast, P. aeruginosa can lose out in the Fe(III) battle to
other organisms such as Burkholderia spp., which produce com-
peting siderophores, such as ornibactin (75), as well as
phenazines. Such positive and negative interactions involving
iron may help explain the dynamic takeovers between different
pathogens in the lungs of CF patients over time. Yet given that
phenazines can alleviate the dependence of Pseudomonas on
Fe(III) by generating Fe(II), competition for Fe(III) may be
relevant only when phenazines are not present. Indeed, it
seems likely that phenazine-enabled Fe(II) generation could
benefit not only phenazine producers like P. aeruginosa but
also other organisms, much in the same way that siderophores
can be used by different species (53, 64).
The full complexity of the microbial community in the CF
lung and the interactions among its members are only be-
ginning to be appreciated (8, 25, 63). Systematic studies are
needed to understand how iron availability—impacted by
both host cells and the microbiome—affects this ecosystem.
As recently pointed out by Reid et al. (59), we do not have
a clear understanding of iron chemistry in CF sputum, and
this must be determined before we can properly understand
how iron might be acquired by P. aeruginosa cells or any
other cell at different stages in lung function decline. In the
future, it will be interesting to determine whether
phenazines—possibly by way of promoting Fe(II) acquisi-
tion, among other effects (17, 18, 27, 28, 54, 55, 57, 73,
74)—influence the composition of the microbial community
present in infections and its stability.
FIG. 5. A highly simplified schematic view of P. aeruginosa iron transport via phenazine-facilitated Fe(II) uptake (right), siderophore-mediated
Fe(III) uptake (middle), and heme uptake (left). In Fe(III) uptake, a siderophore (e.g., pyoverdine, indicated by the star) binds extracellular
Fe(III) and crosses the outer membrane (OM) via a TonB-dependent transporter (53, 64). In the periplasm, Fe(III) is released from the
siderophore, which can then be recycled; Fe(III) is reduced by an unknown mechanism to Fe(II) in the periplasm (P) and transported across the
cytoplasmic membrane (CM), presumably by an ABC transport system (53, 64). By contrast, phenazines can reduce extracellular Fe(III) to Fe(II).
After entering the periplasm, presumably via an OM porin, Fe(II) is transported across the CM via FeoB (11, 40). Phenazines themselves are
recycled (27, 73) and enter and leave the cell through various transporters (not drawn, for simplicity). Intracellularly, phenazine reduction is
coupled to NADH oxidation to NAD (55), although whether this reduction is enzyme mediated is unknown. Reduced phenazine is indicated by
the open oval and oxidized phenazine by the filled oval. Additionally, P. aeruginosa can acquire iron from heme and heme-containing proteins (e.g.,
hemoglobin), which are transported through a specific outer membrane receptor channel in a TonB-dependent manner (31, 48, 72). In P.
aeruginosa, two distinct heme uptake systems have been found, although the mechanistic details of heme capture and delivery and the fate of heme
after entering the cytoplasm are not fully understood (31, 48).
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